British Patient Capital’s Post

British Business Bank’s UK Venture Capital Financial Returns 2024 report shows a positive outlook for life sciences 📈 Life sciences funds have outperformed others with realised returns, showing their resilience and potential. This is significant considering this is a sector often requiring extensive upfront R&D before commercialising 🔬 It's also great to see that British Patient Capital-baked funds are delivering higher median returns than the market across key performance metrics. This shows we are delivering on fueling long-term investments in the UK’s high-potential, innovative companies 🚀 Read our full response to the report's findings here: https://lnkd.in/dnXxssCc #VentureCapital #LifeSciences #BritishPatientCapital #Innovation #Investment

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics